VC Firm Oversees NGM Bio’s $122M Series A Funding After Taking it Private

1. Acquisition and Funding Timeline: The Column Group acquired NGM Bio and took it private three months ago. Since then, the VC firm has overseen a $122 million Series A funding round for the biotech company.
2. Investment Amount: The Series A funding round raised $122 million to fuel NGM Bio's growth and development.
3. The Column Group's Role: The Column Group, the VC firm that took NGM Bio private, played a key role in overseeing the $122 million Series A funding round.
4. NGM Bio's Future: The significant investment is expected to support NGM Bio's continued growth and advancement in the biotech industry.